233 related articles for article (PubMed ID: 22014025)
21. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population.
Zhang LP; Wang CP; Li LH; Tang YF; Li WC
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26918783
[TBL] [Abstract][Full Text] [Related]
22. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
23. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Huang M; Chen Q; Xiao J; Zhao X; Liu C
Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
Nakachi K; Imai K; Hayashi S; Kawajiri K
Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
[TBL] [Abstract][Full Text] [Related]
25. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract][Full Text] [Related]
26. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
27. CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.
Houlston RS
Pharmacogenetics; 2000 Mar; 10(2):105-14. PubMed ID: 10761998
[TBL] [Abstract][Full Text] [Related]
28. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
[TBL] [Abstract][Full Text] [Related]
29. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China.
Song N; Tan W; Xing D; Lin D
Carcinogenesis; 2001 Jan; 22(1):11-6. PubMed ID: 11159735
[TBL] [Abstract][Full Text] [Related]
30. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
31. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
[TBL] [Abstract][Full Text] [Related]
32. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
[TBL] [Abstract][Full Text] [Related]
33. Association Studies of CYP1A1 Exon7 Polymorphism and -GSTM1 Interaction with Esophageal Cancer Risk: a Meta-Analysis in the Chinese Population.
Chen XP; Xu DF; Xu WH; Ma ZC; Yao J; Fu SM
Clin Lab; 2016 Sep; 62(9):1795-1802. PubMed ID: 28164573
[TBL] [Abstract][Full Text] [Related]
34. Association between cytochrome P450 1A1 MspI polymorphism and endometrial cancer risk: a meta-analysis.
Han L; Liu Y; Cao W; Yuan X; Li C
Tumour Biol; 2013 Oct; 34(5):2545-50. PubMed ID: 23918309
[TBL] [Abstract][Full Text] [Related]
35. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
[TBL] [Abstract][Full Text] [Related]
36. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
Wang N; Wu Y; Zhou X; Wu Y
Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
[TBL] [Abstract][Full Text] [Related]
37. CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls.
Vineis P; Veglia F; Benhamou S; Butkiewicz D; Cascorbi I; Clapper ML; Dolzan V; Haugen A; Hirvonen A; Ingelman-Sundberg M; Kihara M; Kiyohara C; Kremers P; Le Marchand L; Ohshima S; Pastorelli R; Rannug A; Romkes M; Schoket B; Shields P; Strange RC; Stucker I; Sugimura H; Garte S; Gaspari L; Taioli E
Int J Cancer; 2003 May; 104(5):650-7. PubMed ID: 12594823
[TBL] [Abstract][Full Text] [Related]
38. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
39. CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation.
Ng DP; Tan KW; Zhao B; Seow A
Cancer Causes Control; 2005 May; 16(4):399-405. PubMed ID: 15953982
[TBL] [Abstract][Full Text] [Related]
40. Lack of association between the CYP1A1 Ile462Val polymorphism and endometrial cancer risk: a meta-analysis.
Wang XW; Zhong TY; Xiong YH; Lin HB; Liu QY
Asian Pac J Cancer Prev; 2012; 13(8):3717-21. PubMed ID: 23098461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
